Lynx Investment Advisory »

West Pharmaceutical Services shares owned by Lynx Investment Advisory

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by Lynx Investment Advisory from 13F filings

Historical chart of Lynx Investment Advisory investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by Lynx Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by Lynx Investment Advisory

Quarter filed Position value Share count Share price at filing
2024-06-30 $86k 261 329.74

More positions owned by Lynx Investment Advisory

Invesco S&p 500 Quality Etf Etf (SPHQ)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Apple Stock (AAPL)
Proshares S&p 500 Dividend Aristocrats Etf Etf (NOBL)
Microsoft Corp Stock (MSFT)
First Trust Dow Jones Global Select Dividend Index Fund Etf (FGD)
Dimensional International Core Equity Market Etf Etf (DFAI)
Spdr Gold Shares Etf Etf (GLD)
Ishares Intl Dividend Growth Etf Etf (IGRO)
Spdr Portfolio S&p 400 Mid Cap Etf Etf (SPMD)
Spdr Gold Minishares Trust Etf (GLDM)
Amazon Stock (AMZN)
Invesco S&p Global Water Index Etf Etf (CGW)
Mastercard Incorporated Cl A Stock (MA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for Lynx Investment Advisory

Top funds holding West Pharmaceutical Services

Vanguard Group
BlackRock
Bank of New York Mellon
State Street Corporation
Artisan Partners Limited Partnership
Franklin Resources
Alliancebernstein
Brown Advisory Holdings Incorporated
Geode Capital Management
T. Rowe Price Associates
T. Rowe Price Investment Management
Durable Capital Partners
Jpmorgan Chase & Co
Bamco
Morgan Stanley

View all funds holding West Pharmaceutical Services